Franklin, Tenn.-based Community Health Systems’ CEO and CFO saw their total compensation decrease in 2024, according to a proxy statement filed March 12 with the Securities and Exchange Commission.
Category: News and Analysis
5 revenue cycle executive moves in February
Becker’s reported on four health systems naming revenue cycle executives and one leader departing for an RCM company in February:
How 4 top pharmacy leaders are leveraging AI for transformation
Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to to share the ways they’re using AI.
APhA launches platform to address pharmacy workforce shortage
The American Pharmacists Association has launched a new platform, Health Shifts, that aims to address workforce shortages in the pharmacy industry.
Woman reaches tentative settlement in ASC lawsuit
A woman who sued an orthopedic ASC claiming its practices “prioritized profit over care” and retaliation reached a tentative settlement, My News LA reported Feb. 6.
AMA's 3 asks for the new Congress
The American Medical Association said the 119th Congress can create “a lasting legacy of health reform” starting with the expedited passage of three pieces of legislation:
How Beth Israel Lahey Health tackled the pandemic
Cambridge, Mass.-based Beth Israel Lahey Health will mark its sixth anniversary as a system this March. Serving eastern Massachusetts and southern New Hampshire, the system operates 14 hospitals and several ambulatory sites. Since its founding, communi…
Healthcare contends with aftermath of UnitedHealthcare CEO's killing: 5 updates
It’s been just over a month since the tragic murder of UnitedHealthcare CEO Brian Thompson sent shockwaves through the healthcare industry and exposed public frustrations with insurers. In the aftermath, tensions have escalated, with healthcare organiz…
Don't 'cannibalize' virtual nurses, nurse leaders say
As health systems tinker with various virtual nursing models, cases for and against on-site programs are emerging.
FDA slow to address concerns in wake of drug recalls: Report
A series of recalls from India-based company Glenmark Pharmaceuticals has raised concerns about the safety of drugs manufactured overseas and the FDA’s role in ensuring public safety, ProPublica reported Dec. 12.
